AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01865279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin degludec
Description: A single dose corresponding to that of isophane human insulin
Study NCT01865279 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: isophane human insulin
Description: A single dose of 0.4 IU/kg is administered to subjects with type 1 diabetes while a single dose of 0.6 IU/kg is administered to subjects with type 2 diabetes
Study NCT01056809 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy and surgery
Description: Treatment not specified but in accordance with national guidelines
Study NCT02902510 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic yoga for people with Parkinson's Disease
Description: Held for 8 weeks, individuals participated in therapeutic yoga 60 minutes 2x/week.
Study NCT04156568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INH、RFT
Description: 6INH 10mg/kg 3INH+RFT 15mg/kg
Study NCT01206179 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cell injection
Description: Injection of mesenchymal cells in fractured zone
Study NCT04553432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Amniotic membrane Omnigen[TM]
Description: 17mm circular disk of processed amniotic tissue donated by mother after birth with a 6mm laser cut aperture to allow unimpeded vision https://www.nu-vision.co.uk/omnigen
Study NCT04553432 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bandage soft Contact Lens OmniLenz[R]
Description: 18mm soft silicone-hydrogel contact lens https://www.nu-vision.co.uk/omnilenz
Study NCT04553432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bandage soft Contact Lens OmniLenz[R]
Description: 18mm soft silicone-hydrogel contact lens https://www.nu-vision.co.uk/omnilenz
Study NCT02443142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Ibuprofen 800 mg orally three times per day for two days for study subjects who are randomized to the ibuprofen arm.
Study NCT02443142 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: Acetaminophen 1000 mg orrally three times per day for two days for subjects who are randomized to the acetaminophen arm.
Study NCT00783445 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-Based Exercise Program (C-FIT)
Description: Participants will do 1 hour of exercise two to three times each week in a community setting for 1 year, while being supervised by a personal coach.
Study NCT00783445 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Help Exercise Program (HOME)
Description: After a fitness evaluation, participants will be given an exercise prescription and recommendations for home-based, self-mediated progressive exercise. Participants will be expected to do 1 hour of exercise two to three times each week for 1 year.
Study NCT01630512 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Description: The intervention consists of 8 weekly individual sessions of MBCT. Each session will be administered individually and will last 45 to 60 minutes.
Study NCT01630512 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Description: The intervention consists of 8 weekly individual sessions of CBT. Each session will be administered individually and will last 45 to 60 minutes.
Study NCT03167879 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: safer conception counseling
Description: Multi-component counseling to help HIV-affected couples to make an informed decision about childbearing, and to provide counseling to use contraception or safer conception methods, depending on whether the couples chooses to seek or prevent pregnancy after initial consultation.
Study NCT02229942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Induction with two infusions two weeks apart, rituximab 500 mg/m2 (max 1000 mg).~Maintenance with rituximab infusions (500 mg fixed dose) at 3, 6, 9 and 12 months.
Study NCT02229942 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline (NaCl 0,9%) added human albumin (Flexbumin) 0,4 mg/ml, two infusions two weeks apart. Maintenance infusions after 3,6, 9 and 12 months.
Study NCT02417688 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cu[64]-25%-CANF-Comb PET-MR
Description: Single IV injection of a novel radiopharmaceutical for diagnostic imaging of atherosclerosis by PET-MR
Study NCT02859051 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Humanoid Robot MEDi
Description: Humanoid robot programmed with cognitive-behavioral interventions such as role modeling, teaching coping strategies, positive reinforcement, parent encouragement
Study NCT01650207 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: All participants were received regular rehabilitation program, and received different interventions.~treatment frequency: 20 minutes per session, once daily, 5 times a week for 2 weeks
Study NCT01650207 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TENS
Study NCT01650207 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham acupuncture
Study NCT03849885 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gel
Description: Skin prep with Chlorohexidine wipes and BPO.
Study NCT02120950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Description: Eylea is administered as an intravitreal injection
Study NCT00182325 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: personalized web prenatal information
Study NCT01147757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: remifentanil
Description: During surgery, 3 different dose of remifentanil or placebo was infused.
Study NCT02120950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visudyne
Description: Photodynamic therapy is a combined therapy of drug (Visudyne) applied to reinforce the action of a device (laser)
Study NCT01147757 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: remifentanil
Description: During surgery, 3 different dose of remifentanil or placebo was infused.
Study NCT03527888 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Anlotinib
Description: Anlotinib QD po and it should be continued until disease progression or intolerable toxicity or patients withdrawal of consent
Study NCT01729793 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Digestive Enzyme #2
Description: Contains dietary supplement proteases, lipases and carbohydrases
Study NCT01729793 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule containing microcrystalline cellulose
Study NCT04565873 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TSH
Description: retrospective TSH level
Study NCT00182325 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: general web prenatal information
Study NCT04258176 — intervention group
Intervention type: OTHER
Intervention: Multidisciplinary outpatient pathway
Description: Coordinators, assigned to improve the care flow, review and align the patient's appointments and tests in agreement with the patient's wishes. Outpatient consultations are arranged to take place the same day and schedules for care providers are coordinated. The patients' attendance in outpatient clinics are planned sequentially where the delivering specialty writes a summary to the subsequent specialty. Afterwards, the involved physicians and nurses attend an interdisciplinary conference, resulting in a joint treatment plan, with feedback and notice of modifications, which is delivered to the patient and general practice.
Study NCT03240783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Betamethasone OR Dexamethasone Injectable
Description: Procedural agents. The steroid and local anaesthetic preparation will be standardized to replicate current radiology interventional practices that use either particulate or non-particulate steroids. Betamethasone Sodium Phosphate/Acetate 5.7 mg/ml Injectable is a particulate corticosteroid and is used with the local anaesthetic bupivacaine 0.5% (1ml). Dexamethasone 4mg (1ml) is a non-particulate corticosteroid and is used with the local anaesthetic lignocaine 1% (1ml).
Study NCT03240783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Normal Saline Flush, 0.9% Injectable Solution
Description: Procedural agents. The local anaesthetic preparation used with the Normal Saline Flush, 0.9% Injectable Solution, will be standardized to replicate current radiology interventional practices: either local anaesthetic bupivacaine 0.5% (1ml) or local anaesthetic lignocaine 1% (1ml).
Study NCT01892631 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text message influenza vaccination reminder
Description: Practices in the text messaging intervention arm will be asked to send a text message to patients under 65 at risk of influenza.
Study NCT01892631 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard care
Description: Practices in the standard care arm will be asked to proceed with their seasonal influenza campaign as planned.
Study NCT04390581 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Juvéderm® VOLIFT with Lidocaine
Description: Consists of one injection of Juvéderm® VOLIFT with Lidocaine to both hands no more than 6ml for both hands total on Day 1. Optional on Day 30.
Study NCT03329690 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: DS-8201a
Description: DS-8201a is comprised of an antibody component conjoined to a drug component in a lyophilized powder, which is made into solution for intravenous administration.
Study NCT03329690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-8201a
Description: DS-8201a is comprised of an antibody component conjoined to a drug component in a lyophilized powder, which is made into solution for intravenous administration.
Study NCT03329690 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Physician's Choice
Description: Either:~Irinotecan monotherapy (Starting dosage and usage is 150 mg/m2 biweekly, with dose reduction permitted)~Paclitaxel monotherapy (Starting dosage and usage is 80 mg/m2 weekly, with dose reduction permitted)
Study NCT00951093 — intervention group
Intervention type: PROCEDURE
Intervention: Gastric bypass
Description: Open Silastic® ring Roux-en Y gastric bypass was performed through an upper midline incision. A gastric pouch was created by dividing the stomach with a 10-cm stapler from the lesser curvature (7 cm vertically from the cardia) to 1 cm to the left of the Hiss angle. The estimated volume of the gastric pouch was 20 to 30 ml that was banded with a 6.5 cm long Silastic® ring. A gastrojejunal anastomosis was performed with two-layers hand sewn absorbable suture over a 1.2 cm bougie distal to the ring, keeping an alimentary limb with 100 cm in length, and a biliopancreatic limb ranging 60 and 80 cm.
Study NCT04773444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eccentric cycling training
Description: 1. Performed exercise training 5 days a week for 6 weeks on an eccentric ergometer.~2. Each training session: 3 min at 30% of maximal workload (Wmax) for warmed up and cold down and 30 min the main training phase.~3. Intensity: Firstly, set at 45% Wmax, and progressively increased 5% per week
Study NCT04773444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Concentric cycling training
Description: 1. Performed exercise training 5 days a week for 6 weeks on an eccentric ergometer.~2. Each training session: 3 min at 30% of maximal workload (Wmax) for warmed up and cold down and 30 min the main training phase.~3. Intensity: Firstly, set at 45% Wmax, and progressively increased 5% per week
Study NCT02746562 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Freeze all
Description: Freezing of all blastocyst stage embryos with thawing and transfer in a subsequent natural cycle
Study NCT01909908 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ECM
Description: ECM in saline applied to wound
Study NCT01909908 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood Products
Description: Autologous blood product applied to wound, with saline cleanse on alternating weeks
Study NCT01909908 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ECM in Blood Products
Description: Alternating treatments of ECM in saline and ECM in autologous blood products, applied to wound
Study NCT02857777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: Subjects will self-administer intranasal esketamine as per the treatment regimen.
Study NCT02857777 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esketamine
Description: Subjects will self-administer intranasal esketamine as per the treatment regimen.
Study NCT03412084 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stand up and move more
Description: 4 week behavioral intervention involving the development and implementation of action plans
Study NCT03610932 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Taken as 3 500mg capsules.
Study NCT03610932 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Taken as 3 500mg capsules.
Study NCT00885066 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine
Study NCT00885066 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib hydrochloride
Study NCT00885066 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine hydrochloride
Study NCT03045965 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Salpingectomy
Description: The intervention is a routine salpingectomy, performed laparoscopically, through laparotomy or vaginally.
Study NCT03869450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Restylane Volyme
Description: Hyaluronic based filler
Study NCT03869450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Restylane Defyne
Description: Hyaluronic based filler
Study NCT03869450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Restylane Lyft Lidocaine
Description: Hyaluronic based filler
Study NCT03823053 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Based Traditional Scoliosis Exercise
Description: Program will include posture exercises, strengthening exercises of interscapular muscle and limb, diaphragmatic breathing exercises and stretching exercises for lumbar extensor, hip flexor, hamstring, pectoral muscles. Exercises will be applied 1 sets of 10 repetitions and once a day.
Study NCT03823053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Based Traditional Scoliosis Exercise
Description: Program will include posture exercises, strengthening exercises of interscapular muscle and limb, diaphragmatic breathing exercises and stretching exercises for lumbar extensor, hip flexor, hamstring, pectoral muscles. Exercises will be applied 1 sets of 10 repetitions and once a day.
Study NCT01394406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: ketamine 3 mg/kg mixed to intravenous patient controlled analgesia device (fentanyl 20 mcg/kg. total volume 180 ml, basal infusion 2 ml, bolus 2ml, lock-out 15 min)
Study NCT01394406 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: equal volume of normal saline mixed to intravenous patient controlled analgesia device
Study NCT03672526 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: measure of injection pressure by compuflo
Description: injection pressure mesured by Compuflo
Study NCT00057408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: olanzapine (Zyprexa)
Description: Olanzapine tablets given po at a dosage of 2.5 - 20 mg per day for up to 12 weeks.
Study NCT00057408 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo
Study NCT04538079 — intervention group
Intervention type: DEVICE
Intervention: Multimodal objective non-invasive Monitoring
Description: Multimodal objective non-invasive monitoring including cerebral oxygenation (NIRS), pulse oximetry with Pulsatility Index (PI) and non-invasive Cardiac Output Monitoring will be recorded but not used for clinical decision making. 2 ECHOs will be performed (one within the first 24h, one in the 2nd 24 hours after birth)
Study NCT02077400 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cephazolin
Description: Cephazolin
Study NCT03465995 — intervention group
Intervention type: DEVICE
Intervention: NKI i-PAS Diagnostic Protocol
Description: The NKI i-PAS:~The NeuroKinetics i-PAS system is a mobile assessment device with an integrated display for eye tracking with the following properties: a head mounted display, a sampling rate of 100 frames per second, eye tracking in the horizontal, vertical and torsional axes, and pupil area measurement with a spatial resolution less than 0.1 o. The testing protocol includes: optokinetic tracking, smooth pursuit horizontal, smooth pursuit vertical, saccade random horizontal, saccade random vertical, saccade predictive horizontal, antisaccade (horizontal), self-paced saccade, saccade and reaction times, visual reaction time, auditory reaction time, gaze horizontal, light reflex, subjective visual (vertical) and subjective vertical horizontal. Several quantitative measures are computed from the data acquired in each test, and these measures are then employed in a multivariate diagnostic assessment.
Study NCT00597415 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: celecoxib
Description: celecoxib 200mg
Study NCT00597415 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT00783458 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mometasone Furoate Nasal Spray
Description: One dose (2 sprays in each nostril) of Mometasone Furoate Nasal Spray
Study NCT00783458 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluticasone nasal spray
Description: One dose (2 sprays in each nostril) of fluticasone nasal spray
Study NCT00558181 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rituximab, methylprednisolone
Description: Subjects will receive up-to 6 courses of IV infusion of Methylprednisolone and Rituximab every 21 day.
Study NCT00418574 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Abagovomab
Description: 2 mg/ml SC (subcutaneously)
Study NCT00418574 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 mg/ml SC (subcutaneously)
Study NCT04672122 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Cathodal tDCS will be applied for 20 mins.
Study NCT04672122 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation
Description: Cathodal tDCS will be applied for 20 mins.
Study NCT03240783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone Oral Tablet
Description: Dexamethasone Oral Tablet: 15 day taper dosing is: days 1-5 8mg (4mg bd) , days 6-10 4 mg (2mg bd), and days 11-15 2 mg (1mg bd). The dexamethasone is over-encapsulated in a gelatine capsule that is identical to the placebo capsule in appearance.
Study NCT03240783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham Injection and/or oral placebo
Description: The sham Injection procedure is needle placement down to muscle at the designated spinal level and no injection of any fluid. The oral placebo is a gelatine capsule packed with filler.
Study NCT03823053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Based Core Stabilization Training
Description: Program will include posture exercises, strengthening exercises of interscapular muscle and limb, diaphragmatic breathing exercises and stretching exercises for lumbar extensor, hip flexor, hamstring, pectoral muscles. In addition, the training group received core stabilization exercises for multifidus, transversus abdominis, diaphragm,erector spines, rectus abdominis, internal and external obliques, quadratus lumborum, gluteus maximus, and pelvic floor muscles.Exercises will be applied 1 sets of 10 repetitions and once a day.
Study NCT00181207 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pneumatic vest
Study NCT00181207 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo pneumatic vest
Study NCT02581696 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Lafutidine
Description: Lafutidine 10mg, 1 tablet, bid
Study NCT02581696 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Irsogladine maleate
Description: Irsogladine maleate 2mg, 2 tablet, qd
Study NCT02053753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab CP4
Description: Denosumab produced by a process referred to as CP4, administered subcutaneously.
Study NCT02053753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab CP2
Description: Denosumab produced by a process referred to as CP2, administered subcutaneously.
Study NCT02203487 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIF 1149 BS - single rising dose
Study NCT02203487 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00712465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1305
Description: Extended Release tablet, repeated administration
Study NCT00712465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Tablet, repeated administration